Deliver Your News to the World

People with congenital heart disease need physical activity


NewMediaWire via Webwire

Statement Highlights:

  • People born with a heart defect need physical activity.
  • Some irregular heart beat conditions may require activity restrictions but for most patients physical activity is unlimited.

EMBARGOED UNTIL 3 p.m. CT/4 p.m. ET, Monday, April 29, 2013 
DALLAS, April 29, 2013 -- A new scientific statement from the American Heart Associations reminds physicians and people with congenital heart disease that regular physical activity is still important and should be promoted.

Congenital heart disease
 heart structural problems existing since birth) is estimated to affect more than 859,000 children and 850,000 adults in the United States.

According to the statement:

  • While some irregular heart beat conditions may require a restriction in physical activity, “for most, physical activity can be unlimited and should be strongly promoted.”
  • Most patients with congenital heart disease are relatively sedentary.  But the physical, psychological and social health benefits of physical activity are important for this population which is at risk for exercise intolerance, obesity and other diseases, according to the statement.
  • The recommendations for activity promotion are based on general recommendations for physical activity for healthy children and adults because only a limited amount of research on physical activity among congenital heart disease patients has been done.

The statement will be published in Circulation, a journal of the American Heart Association.

For the latest heart and stroke news, follow us on Twitter: @HeartNews.


The American Heart Association/American Stroke Association receives funding mostly from individuals. Foundations and corporations donate as well, and fund specific programs and events. Strict policies are enforced to prevent these relationships from influencing the association’s science content. Financial information for the American Heart Association, including a list of contributions from pharmaceutical companies and device manufacturers, is available at

Additional resources, including multimedia resources, are available in the right column of this link:

For Media Inquiries: (214)706-1173
Darcy Spitz: (212) 878-5940;
Bridgette McNeill ;(214) 706-1135;
Julie Del Barto (broadcast): (214) 706-1330;
For Public Inquiries: (800) AHA-USA1 (242-8721) and


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.